The medication is structurally modified to resist degradation by the enzyme dipeptidyl peptidase-4 (DPP-4) and includes an albumin-binding side chain, which extends its duration of action compared to native GLP-1
Wegovy (Semaglutide Injection) Wegovy is the FDA-approved weight loss version of semaglutide, the same active ingredient found in Ozempic
The goal is not just to lose weight
It represents the most common acute optic neuropathy in adults over 50 years of age, affecting approximately 2 to 10 per 100,000 individuals annually in this age group in the United States
Renal Impairment: In patients treated with GLP-1 receptor agonists, including Saxenda , there have been reports of acute renal failure and worsening of chronic renal failure, usually in association with nausea, vomiting, diarrhea, or dehydration, which may sometimes require hemodialysis
the format with the most clinical alignment to approved Wegovy trial protocols Daily oral tablet dissolvable tablet format for patients who prefer needle-free administration Compounded Tirzepatide: Weekly injectable and daily oral tablet both available when clinically appropriate Brand-Name Options: Ozempic available at higher price points when in stock